AllAnalyst Report
logoMorningstarOctober 16, 2020

Aphria Inc.: Aphria Shares Plummet as the Market Focuses on Q1 Hiccups Rather Than Underlying Profit Growth

Symbols
APHA
Sector(s)
Healthcare
Rating
Premium
Current Price
$15.71
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not currently operate in the U.S. due to federal prohibition. The company is focusing on expanding through international cultivation and distribution into the global medical cannabis market. Aphria also offers multiple products under a portfolio of recreational cannabis brands, including B!NGO, Solei, RIFF, and Broken Coast.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE

Analyst Profile

Kristoffer Inton

Director
Kristoffer Inton is director of equity research, basic materials for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He covers gold, aggregates and cement, and uranium companies.Before joining Morningstar in 2013, Inton was an investment banking associate for Guggenheim Securities in New York. Previously, he was an investment banking analyst for Merrill Lynch in Chicago and New York.Inton holds a bachelor’s degree in finance with high honors from the University of Illinois and a master’s degree in business administration with distinction from Northwestern University’s Kellogg School of Management.